← Open Payments lookup

CHRISTINA BELL: Open Payments

NPI 1801919089 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,251 in 150 payments from 20 companies in 2025. Trend: 2023 $2,808 · 2024 $2,932 · 2025 $3,251

Food & beverage: $3,217Education: $34
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP19$572
GlaxoSmithKline, LLC.26$458
Boehringer Ingelheim Pharmaceuticals, Inc.15$315
Takeda Pharmaceuticals U.S.A., Inc.12$298
Regeneron Healthcare Solutions, Inc.14$258
Amgen Inc.13$229
GENZYME CORPORATION8$227
Insmed, Inc.8$175
Verona Pharma, Inc.8$156
United Therapeutics Corporation6$136

Products named: DUPIXENT, TEZSPIRE, TRELEGY ELLIPTA, OFEV, Arikayce, Ohtuvayre, AIRSUPRA, GLASSIA.

Industry payments across AL — which companies pay providers there.